Memo Therapeutics
Memo Therapeutics is an antibody Discovery Technology founded in 2012.
7
Funding Rounds
$83.6m
Money raised
Overview
Memo Therapeutics is an antibody Discovery Technology founded in 2012.
- Website:
- Business model: B2B
- Headquarters: Zürich
- Social accounts: linkedin
Funding
Funding series
Funding Series Analysis
The company Memo Therapeutics has raised a total of $83.6m in funding over 7 rounds.
Key Insights:
- Memo Therapeutics November 2023 Series C Funding Round: $28m
- Memo Therapeutics February 2022 Funding Round: $40m
- Memo Therapeutics May 2018 Series A Funding Round: $5.5m
- Memo Therapeutics May 2018 Series A Funding Round: $5.5m
- Memo Therapeutics July 2015 Series A Funding Round: $2.3m
- Memo Therapeutics July 2015 Series A Funding Round: $2.3m
Memo Therapeutics November 2023 Series C Funding Round
$28m
Memo Therapeutics February 2022 Funding Round
$40m
Memo Therapeutics May 2018 Series A Funding Round
$5.5m
Memo Therapeutics May 2018 Series A Funding Round
$5.5m
Memo Therapeutics July 2015 Series A Funding Round
$2.3m
Memo Therapeutics July 2015 Series A Funding Round
$2.3m
Industries
Memo Therapeutics is active in the following industries: